Nonetheless, germline alterations in DNA damage repair genes such as BRCA1/2, PALB2, and ATM, as well as MMR deficiency, are clinically relevant in PDAC due to their therapeutic implications (20). The gene discussed is ATM; the disease is mismatch repair cancer syndrome 1.